Shire's $30B gambit, Merck's '100% effective' Ebola vaccine, and GSK's latest corruption scandal
Summary: Shire's $30B gambit, Merck's '100% effective' Ebola vaccine, and GSK's latest corruption scandal
Summary: Shire's $30B gambit, Merck's '100% effective' Ebola vaccine, and GSK's latest corruption scandal